Omkar Pharmachem Ltd.

22.40 ▼0%

10 April 2024, 04:00:00 PM

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.omkarpharmachem.co.in
Market Cap 22.59 Cr.
Enterprise Value(EV) 23.08 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 0.20 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) 114.67 Trailing Twelve Months Ending 2023-12
Industry PE 40.96 Trailing Twelve Months Ending 2023-12
Book Value / Share 9.17 Trailing Twelve Months Ending 2023-12
Price to Book Value 2.44 Calculated using Price: 22.40
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 1.01 Cr. 10,084,800 Shares
FaceValue 10
About Omkar Pharmachem Ltd.
The company is engaged in the manufacturing of pharmaceutical chemicals.

Omkar Pharmachem Ltd. Delivery

Delivered Qty
Traded Qty

Omkar Pharmachem Ltd. Performance

1 Day
1 Week
1 Month
-0.36%
3 Month
+2.85%
6 Month
+7.69%
1 Year
-10.40%
2 Year
+15.76%
5 Year
+67.16%
10 Year
+286.87%

Omkar Pharmachem Ltd. Fundamental Ratios

9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) -0.66 -1.27 2.38 -2.77 -4.72 -3.03 2.59 2.09 2.21
Return on Capital Employed (%) -0.66 -1.27 2.91 -2.55 -4.11 -2.22 0.22 2.76 3.2
Return on Assets (%) -0.65 -1.22 2.3 -2.72 -4.49 -2.78 2.36 1.93 2.06

Omkar Pharmachem Ltd. Balance Sheet

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 9 9 9 9 9 8 9 9 9 9
Non Curr. Liab. 0 0 0 0 0
Curr. Liab. 0 1 0 0 1 1 1 1 1 1
Minority Int.
Equity & Liab. 9 10 9 9 9 9 9 10 10 10
Non Curr. Assets 9 9 9 9 9 9 9 9 9 9
Curr. Assets 0 0 0 0 0 0 0 0 0 0
Misc. Exp. not W/O
Total Assets 9 10 9 9 9 9 9 10 10 10

Omkar Pharmachem Ltd. Profit and Loss

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 0 0 1 1 1
Other Income 0
Total Income 0 0 0 1 1 1
Total Expenditure 0 0 0 0 0 0 0 0 0 0
PBIDT 0 0 0 0 0 0 0 0 0 0
Interest 0 0 0 0 0 0 0
Depreciation
Taxation 0 0 0 0 0
Exceptional Items 0
PAT 0 0 0 0 0 0 0 0 0 0
Adjusted EPS 0 0 0 0 0 0 0 0 0 0

Omkar Pharmachem Ltd. Cash Flow

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 0 0 0 -1 0 0 0 0 0 0
Cash Fr. Inv. 0 0 0
Cash Fr. Finan. 0 0 0 0 0 0 0 0
Net Change 0 0 0 0 0 0 0 0
Cash & Cash Eqvt 0 0 0 0 0 0 0 0 0

Omkar Pharmachem Ltd. Shareholding Pattern

9 Qtrs 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%)
Promoter 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03
Public 99.97 99.97 99.97 99.97 99.97 99.97 99.97 99.97 99.97
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
No. of Shareholders (in Lacs)

Omkar Pharmachem Ltd. Announcements

Fri, 12 Apr 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Certificate under regulation 74(5) of the SEBI (Depositories and participants) Regulations 2018 for the quarter ended on March 31 2024
Wed, 27 Mar 2024
Closure of Trading Window
Dear Sir Pursuant to SEBI (Prohibition of Insider Trading Regulations) 2015 as amended and in compliance with the terms of Code of conduct of the company please note that the Trading window for dealing in shares of the company will remain closed for the designated persons and their immediate relatives from Monday 01st April 2024 till the completion of 48 hrs after the date of declaration of Audited financial results of the company for quarter and year ended on 31.03.2024.
Thu, 15 Feb 2024
Announcement under Regulation 30 (LODR)-Newspaper Publication
Dear Sir Please find News papers publication of Quarter and Nine months ended as on 31st December 2023

Omkar Pharmachem Ltd. Technical Scans

Wed, 10 Apr 2024
Opening at High Opening at High
Opening at Low Opening at Low
Close Within 52 Week High Zone Close Within 52 Week High Zone
Close Below Last Month Low Close Below Last Month Low
Closing Near 50 SMA Closing Near 50 SMA

Omkar Pharmachem Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 369,773.51 1,534.30 -0.4%
Cipla Ltd. 111,517.58 1,382.35 +0.1%
Dr. Reddy's Laboratories Ltd. 100,257.78 6,041.00 +0.5%
Divi's Laboratories Ltd. 98,636.18 3,760.00 +1.2%
Zydus Lifesciences Ltd. 94,082.88 948.95 +1.5%
Mankind Pharma Ltd. 90,721.26 2,290.40 +1.0%
Apollo Hospitals Enterprise Ltd. 90,631.78 6,292.40 -0.2%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 41.52 1,534.30 -0.4%
Cipla Ltd. Consolidated 2023-12 30.07 1,382.35 +0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 19.18 6,041.00 +0.5%
Divi's Laboratories Ltd. Consolidated 2023-12 71.32 3,760.00 +1.2%
Zydus Lifesciences Ltd. Consolidated 2023-12 31.64 948.95 +1.5%
Mankind Pharma Ltd. Consolidated 2023-12 52.53 2,290.40 +1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 114.82 6,292.40 -0.2%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.93 1,534.30 -0.4%
Cipla Ltd. Consolidated 2023-12 4.31 1,382.35 +0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.73 6,041.00 +0.5%
Divi's Laboratories Ltd. Consolidated 2023-12 7.57 3,760.00 +1.2%
Zydus Lifesciences Ltd. Consolidated 2023-12 4.99 948.95 +1.5%
Mankind Pharma Ltd. Consolidated 2023-12 10.21 2,290.40 +1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 13.42 6,292.40 -0.2%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,534.30 -0.4%
Cipla Ltd. Consolidated 2023-03 0.02 1,382.35 +0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,041.00 +0.5%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,760.00 +1.2%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 948.95 +1.5%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 2,290.40 +1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,292.40 -0.2%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,534.30 -0.4%
Cipla Ltd. Consolidated 2023-03 12.85 1,382.35 +0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,041.00 +0.5%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,760.00 +1.2%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 948.95 +1.5%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,290.40 +1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,292.40 -0.2%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,534.30 -0.4%
Cipla Ltd. Consolidated 2023-03 12.85 1,382.35 +0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,041.00 +0.5%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,760.00 +1.2%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 948.95 +1.5%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,290.40 +1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,292.40 -0.2%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,534.30 -0.4%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,382.35 +0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,041.00 +0.5%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,760.00 +1.2%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 948.95 +1.5%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 2,290.40 +1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,292.40 -0.2%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,534.30 -0.4%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,382.35 +0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,041.00 +0.5%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,760.00 +1.2%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 948.95 +1.5%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 2,290.40 +1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,292.40 -0.2%

Omkar Pharmachem Ltd. FAQ's

What is Omkar Pharmachem share price?

Can I buy Omkar Pharmachem shares now?

What is the Market Cap of Omkar Pharmachem?

What are the key metrics to analyse Omkar Pharmachem?

What is the 52 Week High and Low of Omkar Pharmachem?